SOYACAL 20% (soybean oil) by HBM Alpha Therapeutics is patients, providing macronutrients (amino acids, dextrose and lipids) and micronutrients (electrolytes) parenterally. Approved for total parenteral nutrition-induced cholestasis, lactation. First approved in 1983.
Drug data last refreshed 22h ago · AI intelligence enriched 2w ago
SOYACAL 20% is a soybean oil-based intravenous lipid emulsion used for total parenteral nutrition (TPN), delivering macronutrients (lipids, amino acids, dextrose) and micronutrients parenterally. It is indicated for TPN-induced cholestasis and lactation support. The drug works by providing essential fatty acids and calories through beta-oxidation, while supporting membrane structure, gene expression, and bioactive molecule synthesis.
This 40-year-old legacy product is approaching loss of exclusivity with moderate competitive pressure (30/100), indicating shrinking commercial teams and defensive rather than growth-focused strategy.
patients, providing macronutrients (amino acids, dextrose and lipids) and micronutrients (electrolytes) parenterally. The amino acids provide the structural units that make up proteins and are used to synthesize proteins and other biomolecules or are oxidized to urea and carbon dioxide as a source…
Worked on SOYACAL 20% at HBM Alpha Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Soybean Oil Trial of cArdiovascular Risk
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers
This legacy product offers limited career growth; roles are primarily defensive and operations-focused, centering on cost control, manufacturing efficiency, and supply security rather than innovation or market expansion. Career progression is constrained by the product's mature lifecycle and commoditized market position.